BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Lorien Health Systems To Roll Out SIM™ Across Its U.S. Facilities

  September 16, 2014

   · 

  3 min read
• BioCapital

  Antisense Therapeutics Limited Release: ATL1102 For MS Further Development Plans – U.S. FDA Pre-IND Response Timing Confirmed; European Patent Allowance

  September 16, 2014

   · 

  3 min read
• Business

  Dimension Therapeutics Appoints New CEO, Dr. Annalisa Jenkins

  September 16, 2014

   · 

  3 min read
• Drug Development

  Experimental Northwest Biotherapeutics Drug Gets First Slot Under UK Early Access Scheme

  September 16, 2014

   · 

  6 min read
• Pharm Country

  New York Blood Center Receives $2 Million In NIDA Funding To Develop HIV Self-Testing Intervention

  September 16, 2014

   · 

  3 min read
• Deals

  Alere Inc.'s Ex- CEO Wants To Make $3.82 Billion Buyout Offer

  September 16, 2014

   · 

  2 min read
• Deals

  Israeli Biotech NeuroDerm Ltd. Files For $65 Million IPO

  September 16, 2014

   · 

  2 min read
• Business

  GlaxoSmithKline Exercises Option For Five Prime Therapeutics, Inc.'s Skeletal Muscle Drugs

  September 16, 2014

   · 

  3 min read
• Biotech Beach

  Ignyta Announces RXDX-101 Phase I Data Presentation At The 2014 ESMO Congress

  September 16, 2014

   · 

  1 min read
• Business

  Galen Signs Exclusive Deal in Europe

  September 16, 2014

   · 

  3 min read